Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamma-OH for sleep in ICU patients difficult to wean from mechanical ventilation
2019-002411-26Phase 2Terminated
- Sponsor
- CHU de Poitiers
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sodium oxybate in sleep disorder, sponsored by CHU de Poitiers. Primary endpoint: Proportion of patients having poor sleep with Gamma-OH. Started Sep 2019; status: terminated.
02
Drugs
sodium oxybate
03
Conditions
sleep disorder
Beyond the preview
Go deeper on 2019-002411-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002411-26.